Chapter 1. OMEGA-3 MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. OMEGA-3 MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. OMEGA-3 MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. OMEGA-3 MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. OMEGA-3 MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. OMEGA-3 MARKET– By Product Type

6.1. Liquid Form

6.2. Tablet or Capsule Form

Chapter 7. OMEGA-3 MARKET– By Source

7.1. Animals

       7.1.1. Krill oil

       7.1.2. Fish oil

7.2. Plants

       7.2.1. Flaxseed oil

       7.2.2. Algae oil

Chapter 8. OMEGA-3 MARKET– By End Use

8.1. Dietary Supplements

8.2. Functional Food Ingredients

8.3. Pharmaceuticals

8.4. Infant Nutrition Formulas

8.5. Veterinary Supplements

Chapter 9. OMEGA-3 MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. OMEGA-3 MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10